Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/10/2019
SIETES contiene 92826 citas

 
 
 1 a 20 de 28 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
McCartney M. How the UK regulator became the herbalists' marketeer. BMJ 2014;348:g3194. [Ref.ID 98013]
2.Enlace a cita original
Tsai HH, Lin HW, Pickard SA, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice 2012;66:1056-78. [Ref.ID 93669]
3. Cita con resumen
Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, Roehrborn CG, Crawford ED, Foster Jr HE, Kaplan SA, McCullough A, Andriole GL, Naslund MJ, Williams OD, Kusek JW, Meyers CM, Betz JM, Cantor A, McVary KT, for the Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Study Group. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms. A randomized trial. JAMA 2011;306:1344-51. [Ref.ID 91218]
4. Cita con resumen
Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065-76. [Ref.ID 89970]
5. Cita con resumen
Lapi F, Gallo E, Giocaliere E, Vietri M, Baronti R, Pieraccini G, Tafi A, Menniti-Ippolito F, Mugelli A, Firenzuoli F, Vannacci A. Acute liver damage due to Serenoa rapens: a case report. Br J Clin Pharmacol 2010;69:558-60. [Ref.ID 88446]
6.Enlace a cita original
Bosch M, Bonafont X. Efecte de l'ús de plantes medicinals en el període perioperatori. Butlletí d'Informació Terapèutica 2009;21:19-24. [Ref.ID 86922]
7.
Agbabiaka TB, Pittler MH, Wider B, Ernst E. Serenoa repens (saw palmetto): a systematic review of adverse events. Drug Saf 2009;32:637-47. [Ref.ID 86588]
8.Tiene citas relacionadas
Bent S, Kane C, Avins AL. Saw palmetto for benign prostatic hyperplasia. The authors reply. N Engl J Med 2006;354:1950-1. [Ref.ID 76920]
9.Tiene citas relacionadas
Dimitrakov JD. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006;354:1950. [Ref.ID 76919]
10.Tiene citas relacionadas
Casner PR. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006;354:1950. [Ref.ID 76918]
11.Tiene citas relacionadas
DiPaola RS, Morton RA. Proven and unproven therapy for benign prostatic hyperplasia. N Engl J Med 2006;354:632-4. [Ref.ID 76142]
12.Tiene citas relacionadas Cita con resumen
Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006;354:557-66. [Ref.ID 76137]
13.
Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Anderson TE, Mitchell AA. Recent trends in use of herbal and other natural products. Arch Intern Med 2005;165:281-95. [Ref.ID 72799]
14. Cita con resumen
Thorpe A, Neal D. Benign prostatic hyperplasia. Lancet 2003;361:1359-67. [Ref.ID 65789]
15. Cita con resumen
Pandha HS, Kirby RS. PC-SPES: phytotherapy for prostate cancer. Lancet 2002;359:2213-4. [Ref.ID 62928]
16. Cita con resumen
Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001;61:2163-75. [Ref.ID 60400]
17.
Bala K. Traditional medicine and public policy. Hai News 2000;113-114:1-9. [Ref.ID 53165]
18.
Vickers A. Complementary medicine. BMJ 2000;321:683-6. [Ref.ID 52834]
19. Cita con resumen
Ernst E. Herbal medicines: where is the evidence?. BMJ 2000;321:395-6. [Ref.ID 52403]
20.
De Smet PAGM, Bonsel G, Van der Kuy A, Hekster YA, Pronk M H, Brorens MJA, Lockefeer JHM, Nuijten M J C. Introduction to pharmacoeconomics of herbal medicines. Pharmacoeconomics 2000;18:1-7. [Ref.ID 51664]
Seleccionar todas
 
 1 a 20 de 28 siguiente >>